GlassScriptPhysician profile
Katarzyna Schuld
NPI 1609258102
$3,352.65
in general payments reported to CMS, 2019-2025
18 companies · $426 in 2025
The $426 reported for 2025 was more than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2022: $121 · 2023: $1,360 · 2024: $1,339 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,596 · Education: $380 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,595.59 |
| Education | $379.97 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $738.09 | 2019-2025 | |
| Glaxosmithkline, LLC. | $462.22 | 2023-2024 | Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $357.16 | 2023-2024 | Breztri, Airsupra, Fasenra |
| Inspire Medical Systems, INC. | $266.43 | 2023-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.15 | 2023-2024 | Spiriva Respimat, Stiolto Respimat, Ofev |
| Harmony Biosciences LLC | $177.20 | 2022-2024 | Wakix |
| Grifols USA, LLC | $171.55 | 2022-2023 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $154.22 | 2022-2024 | Acthar |
| Mylan Specialty L.P. | $143.45 | 2024 | Yupelri |
| Avadel Cns Pharmaceuticals, LLC | $125.01 | 2023-2024 | Lumryz |
| Lilly USA, LLC | $125.00 | 2025 | Zepbound |
| Vanda Pharmaceuticals INC. | $113.73 | 2023 | Hetlioz |
| Takeda Pharmaceuticals U.S.A., INC. | $109.27 | 2023-2024 | Glassia |
| Axsome Therapeutics, INC. | $90.08 | 2023-2024 | Sunosi |
| Baxter Healthcare | $49.03 | 2023 | Hillrom - Life 2000 Ventilation System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $30.82 | 2023-2024 | Recarbrio, Zerbaxa, Dificid |
| Csl Behring | $19.87 | 2024 | Hizentra |
| E.R. Squibb & Sons, L.L.C. | $16.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katarzyna Schuld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.